Proton Rahman Selected Research

protein kinase C eta

5/2007	Progressive and concordant expression of PKC-eta and iNOS phenotypes in monocytes from patients with rheumatoid arthritis: association with disease severity.
12/2003	Elevated serum nitric oxide levels in patients with inflammatory arthritis associated with co-expression of inducible nitric oxide synthase and protein kinase C-eta in peripheral blood monocyte-derived macrophages.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Proton Rahman Research Topics

Disease

49	Psoriatic Arthritis 06/2022 - 09/2005
35	Psoriasis (Pustulosis Palmaris et Plantaris) 01/2022 - 01/2007
23	Ankylosing Spondylitis 01/2021 - 10/2005
10	Rheumatoid Arthritis 01/2021 - 01/2007
9	Pain (Aches) 09/2021 - 03/2016
8	Inflammation (Inflammations) 04/2022 - 12/2003
8	Infections 01/2022 - 06/2009
7	Arthritis (Polyarthritis) 01/2022 - 12/2003
6	Axial Spondyloarthritis 09/2021 - 04/2016
5	Knee Osteoarthritis 01/2021 - 02/2006
4	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 12/2021 - 04/2011
4	Fatigue 09/2021 - 07/2011
4	Osteoarthritis 01/2021 - 01/2020
4	Necrosis 12/2020 - 06/2014
3	Crohn Disease (Crohn's Disease) 10/2018 - 01/2005
3	Systemic Lupus Erythematosus (Libman-Sacks Disease) 03/2012 - 09/2003
2	Injection Site Reaction 12/2021 - 01/2020
2	Musculoskeletal Pain 01/2021 - 01/2021
2	Disease Progression 12/2018 - 05/2007
2	Back Pain (Backache) 04/2016 - 10/2008
1	Hypertrophy 04/2022
1	Insulin Resistance 04/2022
1	Obesity 04/2022
1	Opportunistic Infections (Opportunistic Infection) 12/2021
1	Tuberculosis (Tuberculoses) 12/2021
1	Uveitis 12/2021
1	Neoplasms (Cancer) 12/2021
1	COVID-19 09/2021
1	Non-Radiographic Axial Spondyloarthritis 03/2021
1	Muscle Weakness 01/2021
1	Chronic Disease (Chronic Diseases) 01/2021
1	Skin Manifestations 01/2021
1	Postoperative Pain 01/2020
1	Skin Diseases (Skin Disease) 01/2019
1	Sacroiliitis 01/2019
1	Dyslipidemias (Dyslipidemia) 01/2018

Drug/Important Bio-Agent (IBA)

11	Monoclonal AntibodiesIBA 01/2022 - 08/2013
11	Biological ProductsIBA 01/2022 - 04/2009
11	C-Reactive ProteinIBA 01/2021 - 10/2008
11	Ustekinumab (CNTO 1275)FDA Link 01/2020 - 08/2013
8	ixekizumabIBA 09/2021 - 10/2017
8	secukinumabIBA 01/2021 - 09/2015
7	guselkumabIBA 06/2022 - 01/2020
7	Interleukin-17 (Interleukin 17)IBA 03/2021 - 09/2015
6	Interleukin-23 (Interleukin 23)IBA 01/2022 - 04/2008
6	Infliximab (Remicade)FDA Link 11/2020 - 08/2010
6	ametantrone (HAQ)IBA 01/2019 - 07/2011
5	Biomarkers (Surrogate Marker)IBA 09/2021 - 10/2008
5	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 12/2020 - 01/2005
5	golimumab FDA Link 11/2020 - 08/2017
5	HLA-B Antigens (HLA-B)IBA 12/2018 - 07/2013
5	NF-kappa B (NF-kB)IBA 05/2012 - 09/2005
4	InterleukinsIBA 12/2021 - 08/2010
4	Lysophosphatidylcholines (Lysophosphatidylcholine)IBA 01/2021 - 01/2016
4	CytokinesIBA 01/2020 - 01/2007
4	Phosphatidylcholines (Phosphatidylcholine)IBA 01/2020 - 01/2016
4	Interleukin-12 (IL 12)IBA 10/2018 - 02/2008
4	Interleukin-1 (Interleukin 1)IBA 06/2009 - 10/2005
3	EnzymesIBA 08/2013 - 07/2010
2	Phenylalanine (L-Phenylalanine)FDA Link 04/2022 - 01/2021
2	Proteins (Proteins, Gene)FDA Link 01/2021 - 11/2017
2	InterferonsIBA 06/2019 - 01/2017
2	Tumor Necrosis Factor InhibitorsIBA 01/2019 - 03/2012
2	Genetic Markers (Genetic Marker)IBA 12/2018 - 10/2018
2	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 01/2018 - 04/2015
2	P-2 (P 2)IBA 01/2017 - 11/2010
2	Methotrexate (Mexate)FDA LinkGeneric 12/2016 - 07/2010
2	HLA Antigens (Human Leukocyte Antigens)IBA 09/2015 - 10/2013
2	Interleukin-13IBA 06/2015 - 09/2011
2	AminopeptidasesIBA 07/2013 - 07/2011
2	Peptides (Polypeptides)IBA 07/2013 - 07/2011
2	thiopurine methyltransferase (thiopurine S-methyltransferase)IBA 08/2011 - 04/2011
2	Adalimumab (Humira)FDA Link 10/2008 - 12/2007
2	Toll-Like Receptor 4IBA 05/2008 - 02/2007
2	protein kinase C etaIBA 05/2007 - 12/2003
1	Glucose (Dextrose)FDA LinkGeneric 04/2022
1	Amino Acids FDA Link 04/2022
1	Branched-Chain Amino AcidsIBA 04/2022
1	Insulin (Novolin)FDA Link 04/2022
1	Phospholipids (Phosphatides)FDA LinkGeneric 04/2022
1	Tryptophan (L-Tryptophan)FDA Link 04/2022
1	Immunoglobulin A (IgA)IBA 01/2022
1	AntibodiesIBA 12/2021
1	LDL Lipoproteins (beta Lipoproteins)IBA 01/2021
1	HDL CholesterolIBA 01/2021
1	Arginine (L-Arginine)FDA Link 01/2021
1	Macrophage Migration-Inhibitory FactorsIBA 01/2021
1	tildrakizumabIBA 01/2021
1	Messenger RNA (mRNA)IBA 01/2021
1	SphingomyelinsIBA 01/2021
1	rho GTP-Binding Proteins (rho GTP-Binding Protein)IBA 12/2020
1	Glutamine (L-Glutamine)FDA Link 01/2020
1	Interleukin-23 Subunit p19IBA 01/2020
1	Isoleucine (L-Isoleucine)FDA Link 01/2020
1	Acetylcarnitine (Alcar)IBA 01/2020

Therapy/Procedure

11	Therapeutics 01/2021 - 09/2003
3	Replacement Arthroplasty 01/2021 - 01/2020
3	Biological Therapy 12/2020 - 11/2011
1	Diet Therapy (Therapy, Diet) 04/2022
1	Immunomodulation 01/2018